HX-020

N/A

Report date: 2021/12/24 15:25:42

Base Information

Drug NameHX-020
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Cluster of differentiation 47Anti-TGF-β
TargetsCluster of differentiation 47Transforming growth factor beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesHanx Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanx Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A